Get the Stockscreener App
13.73
0.22%
-0.03
Artelo Biosciences Inc stock is traded at $13.73, with a volume of 39,662.
It is down -0.22% in the last 24 hours and up +124.16% over the past month.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
See More
Previous Close:
$13.76
Open:
$14.18
24h Volume:
39,662
Relative Volume:
0.07
Market Cap:
$7.51M
Revenue:
-
Net Income/Loss:
$-9.60M
P/E Ratio:
-4.3449
EPS:
-3.16
Net Cash Flow:
$-8.96M
1W Performance:
-8.16%
1M Performance:
+124.16%
6M Performance:
+93.93%
1Y Performance:
+64.63%
1-Day Range:
$13.30
$14.27
1-Week Range:
$12.67
$15.44
52-Week Range:
$4.9176
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Name
Artelo Biosciences Inc
Sector
Industry
Phone
858-925-7049
Address
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
13.73 | 9.69M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | D. Boral Capital | Hold → Buy |
| Feb-12-21 | Initiated | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Stock (ARTL) Latest News
What catalysts could drive Artelo Biosciences Inc. stock higher in 2025Stock Market Ideas With Proven Results - jammulinksnews.com
Is Artelo Biosciences Inc. a growth stock or a value stockInvest confidently with professional market insights - jammulinksnews.com
What are analysts’ price targets for Artelo Biosciences Inc. in the next 12 monthsDiscover stocks with explosive potential - jammulinksnews.com
What are the latest earnings results for Artelo Biosciences Inc.Build wealth faster with consistent investment plans - jammulinksnews.com
How volatile is Artelo Biosciences Inc. stock compared to the marketRealize exceptional returns through smart trading - jammulinksnews.com
Why is Artelo Biosciences Inc. stock attracting strong analyst attentionUnmatched market gains - jammulinksnews.com
How does Artelo Biosciences Inc. generate profit in a changing economyOutstanding capital appreciation - jammulinksnews.com
Is Artelo Biosciences Inc. a Top Dividend Stock to Watch in 2025Small Risk Large Return Trades - Newser
What makes Artelo Biosciences Inc. stock price move sharplyBreakout Momentum Stocks - Newser
Artelo Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayElite Stock Shortlist - Newser
Sectors Driving Future Growth for Artelo Biosciences Inc. StockFree Access to Community with 300% Return - Newser
Is Artelo Biosciences Inc. a good long term investmentLightning-fast capital gains - PrintWeekIndia
What analysts say about Artelo Biosciences Inc. stockSky-high profits - PrintWeekIndia
How Artelo Biosciences Inc. stock performs during market volatility5x Profit Potential - Newser
Artelo Biosciences Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional
What drives Artelo Biosciences Inc. stock priceFree Expert Stock Watchlist - jammulinksnews.com
Artelo Biosciences Announces $6.5 Million At-The-Market Offering Agreement - AInvest
Artelo Biosciences' ATM Offering: A Delicate Balance Between Liquidity and Dilution - AInvest
Artelo Biosciences Announces At-The-Market Offering Agreement - TipRanks
What analysts say about Artelo Biosciences Inc. stock outlookMinimized Risk Maximum Return - Newser
Artelo Biosciences: KDJ Golden Cross, Bullish Marubozu on 15-Minute Chart - AInvest
Why Artelo Biosciences Inc. stock attracts strong analyst attentionFree Join Group - Newser
Artelo Biosciences Inc Stock (ARTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.97%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):